HCA Aktie

 

WASHINGTON (dpa-AFX) - HCA Healthcare, Inc. (HCA) announced earnings for third quarter of $1.579 billionThe company's bottom line came in at $1.579 billion, or $7.27 per share. This compares with ......

The operator of healthcare facilities on posted net income of $1.58 billion, compared with $1.64 billion in the same quarter a year ago....

Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the third quarter ended September 30, 2026. Key third quarter metrics (all percentage changes compare 3Q 2026 to 3Q 2025 unless otherwise noted): Revenues increased 3.6 percent to $19.849 billion Net income attributable to HCA Healthcare, Inc. declined 3.9 percent to $1.579 billion Diluted earnings per share increased 4.5 percent to $7.27 per diluted share, and diluted earnings per share, as adjusted, increased 3.7 percent to $7.22 per diluted share Adjusted EBITDA increased 1.2 percent to $3.918 billion Cash flows from operating activities totaled $4.461 billion, compared to $4.416 billion in the third quarter of 2025 Same facility admissions increased 2.7 percent and same facility equivalent admissions increased 3.0 percent "I have often mentioned that HCA has strong staying power because of our scale, the important role we play in providing critical services to communities, and o...

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores....

HCA's Q3 results could benefit from higher admissions, occupancy and inpatient revenues, but rising costs and fewer outpatient surgeries cloud the outlook....

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service....

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards....

Medical device industry veteran and former HCA Healthcare executive to lead commercial preparations and health system partnerships for the investigational Endoluminal Surgical SystemHOUSTON--(BUSINESS WIRE)--EndoQuest Robotics, Inc., a developer of flexible robotic technology for endoluminal procedures, today announced the appointment of Jared Eben as Chief Commercial Officer. Eben will lead commercial strategy and health system partnerships as the company targets a 2027 U.S. launch of its Endoluminal Surgical (ELS) System, subject to FDA marketing authorization.Eben previously served as Vice President of Robotics, AI and Neuroscience at HCA Healthcare and brings a rare blend of health system and medical device leadership to the company. He has nearly two decades of experience across surgical robotics, digital surgery, operating room integration, and healthcare technology commercialization. He has held executive, operational and commercial leadership roles at Allairo, Apella, HCA Healthcare, Proximie, Aur...

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast: What: HCA Healthcare, Inc. 3Q 2026 Earnings Call When: Tuesday, October 27, 2026, at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. Contacts INVESTOR CONTACT:Frank Morgan 615-344-2688 MEDIA CONTACT:Harlow Sumerford 615-344-1851...

New deployment demonstrates how autonomous delivery robots can integrate with complex hospital infrastructure while supporting hospital teams and patient care SAN JOSE, Calif., Sept. 30, 2026 /PRNewswire/ -- Relay Robotics, a leader in autonomous delivery robots, today announced the new......

Partnership Marks Solis Mammography's First Location in South Carolina ADDISON, Texas, Sept. 29, 2026 /PRNewswire/ -- Solis Mammography, the nation's largest independent provider of specialized breast health services, and HCA Healthcare Trident Hospital have established a new joint......

HCA's rising admissions and shorter hospital stays could help it meet growing patient demand while using existing capacity more efficiently....

NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation......

HCA Healthcare's healthy volume growth faces payer-mix pressure, but cost controls, network expansion and Medicaid payments may support earnings growth....

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that it has completed the previously announced acquisition of The College of Health Care Professions (CHCP). As communities grow and healthcare needs continue to evolve, developing the next generation of caregivers is essential to helping ensure patients have access to the skilled healthcare professionals they need. The acquisition of CHCP builds on HCA Healthcare's longstanding commitment to healthcare education and the creation of additional pathways for students to pursue careers in allied health and serve patients in their communities. HCA Healthcare currently supports the education and development of nurses through Galen College of Nursing, Research College of Nursing and Mercy School of Nursing. Additionally, HCA Healthcare is a national leader and sponsor of Graduate Medical Education, with more than 365 programs across 87 hospitals. “CHCP has a strong track reco...

Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

NEW YORK, Sept. 3, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation......